SHL Medical
Paolo S. Ravaynia, PhD, is a Senior Testing Engineer at SHL Medical, where expertise in Combination Products and drug delivery systems performance testing is applied to various projects. Responsibilities include planning and executing design characterization, developing and validating testing methods, analyzing results, and leading the establishment of a new testing lab in Zug, Switzerland. Previous experience includes roles at ETH Zürich as a Postdoctoral Researcher and Ph.D. Researcher, where Paolo supervised master thesis projects and intern projects, focusing on microfluidic systems and drug analysis. Earlier roles also include Development Engineer at Restech, contributing to the development of respiratory mechanics analysis systems. Academic qualifications include a Ph.D. from ETH Zürich and advanced degrees in Biomedical Engineering from Politecnico di Milano.
SHL Medical
8 followers
SHL Medical is a world-leading solutions provider of advanced drug delivery systems, such as autoinjectors. Driven by our company purpose – Enabling Patients’ Independence, we partner with leading pharma and biotech companies to pioneer the development of patient-centric solutions that support the enhancement of patients’ quality of life through self-injection systems as well as digital healthcare solutions. With over 5,000 employees located across our Switzerland, USA, Sweden and Taiwan offices, we rely on our comprehensive in-house manufacturing capabilities to provide end-to-end services, from design, development to final assembly, labeling, and packaging.